Effects of Xiaocangping tablets combined with 5-fluorouracil and cisplatin on immunity, tumor markers, angiogenesis and related factors in patients with advanced esophageal cancer

Effects of Xiaocangping tablets combined with 5-fluorouracil and cisplatin on immunity, tumor markers, angiogenesis and related factors in patients with advanced esophageal cancer

Objective: To explore the effects of Xiaocangping tablets combined with 5-fluorouracil and cisplatin on immunity, tumor markers, angiogenesis and related factors in patients with advanced esophageal cancer. Methods: 86 patients with advanced esophageal cancer admitted to our hospital from March 2...

Full description

Bibliographic Details
Main Authors:	Zhi-Liang Yang, Peng Zhang, Zhi-Ming Tan, Zhi-Zhong Pu
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2019-04-01
Series:	Journal of Hainan Medical University
Subjects:	xiaocangping 5-fluorouracil+cisplatin advanced esophageal cancer immunity tumor markers angiogenesis related factors
Online Access:	http://www.hnykdxxb.com/PDF/201908/15.pdf

Similar Items

Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid–polymer hybrid nanoparticles
by: Qingxia Fu, et al.
Published: (2020-01-01)

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
by: Yun Chen, et al.
Published: (2018-02-01)

Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients
by: Hirotake Saito, et al.
Published: (2018-02-01)

Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature
by: Tomoko Yoshimoto, et al.
Published: (2018-02-01)

Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies
by: Seiichiro Mitani, et al.
Published: (2019-04-01)

Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
by: K Govind Babu, et al.
Published: (2018-01-01)

Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)
by: Oertel Katrin, et al.
Published: (2012-10-01)

ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma
by: Zhang B, et al.
Published: (2019-01-01)

Effects of oxaliplatin, leucovorin and fluorouracil on serum tumor markers, VEGF, CRP and matrix metalloproteinases in patients with advanced esophageal cancer
by: Lei Lei, et al.
Published: (2017-08-01)

Genetic variability & chemotoxicity of 5-fluorouracil & cisplatin in head & neck cancer patients: a preliminary study
by: Dipali Dhawan, et al.
Published: (2013-01-01)

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
by: Nishiguchi Kohshi, et al.
Published: (2011-10-01)

Dramatic response to modified docetaxel, cisplatin, and fluorouracil chemotherapy after immunotherapy in a patient with refractory metastatic anal cancer
by: Faisal Shahjehan, et al.
Published: (2019-09-01)

Barrett’s esophagus and esophageal adenocarcinoma: biomarkers of proliferation, apoptosis, autophagy and angiogenesis
by: E. S. Petenyova, et al.
Published: (2021-01-01)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
by: Xi-Lei Zhou, et al.
Published: (2021-05-01)

CD24 Expression Is Increased in 5-Fluorouracil-Treated Esophageal Adenocarcinoma Cells
by: Pilar Jiménez, et al.
Published: (2017-05-01)

LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells
by: Shuyao Zhang, et al.
Published: (2020-07-01)

Effect of docetaxel + oxaliplatin + S-1 and docetaxel + cisplatin + fluorouracil on treatment of advanced gastric cancer
by: Wei Li, et al.
Published: (2016-09-01)

Autophagy Inhibitor (LY294002) and 5-fluorouracil (5-FU) Combination-Based Nanoliposome for Enhanced Efficacy Against Esophageal Squamous Cell Carcinoma
by: Ye Feng, et al.
Published: (2018-10-01)

Long-term outcomes and safety of radical transmediastinal esophagectomy with preoperative docetaxel, cisplatin, and 5-fluorouracil combination chemotherapy for locally advanced squamous cell carcinoma of the thoracic esophagus
by: Yukinori Yamagata, et al.
Published: (2020-09-01)

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix
by: Sapna Marcus, et al.
Published: (2018-07-01)

The Effect of Curcumin and Tetrahydrocurcumin in Combination with 5-fluorouracil on Esophageal Cancer Cell Lines
by: Pendleton, Emily Grace
Published: (2015)

Effects of SC-560 in Combination with Cisplatin or Taxol on Angiogenesis in Human Ovarian Cancer Xenografts
by: Wei Li, et al.
Published: (2014-10-01)

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review
by: Fatemeh Atashi, et al.
Published: (2021-08-01)

MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression
by: Jingjing Lin, et al.
Published: (2016-01-01)

Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression
by: Kikuchi, Osamu
Published: (2016)

Effect of surgical resection combined with intraperitoneal fluorouracil implants placement on the long-term advanced gastric cancer recurrence and malignant molecule expression
by: Qiang Lu1, et al.
Published: (2017-05-01)

Decreased Oxygen Transfer Capacity of Erythrocytes as a Cause of 5-Fluorouracil Related Ischemia
by: Ivan SpasojeviÃ„Â‡, et al.
Published: (2008-12-01)

Antitumor Efficacy and Mechanisms of Lapatinib in Combination with Cisplatin on Esophageal Squamous Cancer Cells
by: DOU Qiaohua, et al.
Published: (2019-09-01)

Knockdown of miR-183 Enhances the Cisplatin-Induced Apoptosis in Esophageal Cancer Through Increase of FOXO1 Expression
by: Chen H, et al.
Published: (2020-08-01)

The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma
by: Yakup Bozkaya, et al.
Published: (2017-05-01)

Estudo dos efeitos da terapia combinada orlistat / cisplatina / 5-fluorouracil / paclitaxel em linhagem metastática de carcinoma espinocelular de língua
by: Moreira, Fernanda dos Santos, 1986-
Published: (2014)

Urachal Carcinoma with Choroidal, Lung, Lymph Node, Adrenal, Mammary, and Bone Metastases and Peritoneal Carcinomatosis Showing Partial Response after Chemotherapy Treatment with a Modified Docetaxel, Cisplatin and 5-Fluorouracil Regimen
by: Kathleen Dekeister, et al.
Published: (2016-04-01)

Effects of endostatin combined with pemetrexed and cisplatin on the levels of TNF-α, NSE, CEA, CA199, AFP and CYFRA21-1 in patients with advanced lung adenocarcinoma
by: Min Zhang, et al.
Published: (2017-10-01)

Effects of endostatin combined with pemetrexed and cisplatin on the levels of TNF-α, NSE, CEA, CA199, AFP and CYFRA21-1 in patients with advanced lung adenocarcinoma
by: Min Zhang, et al.
Published: (2017-10-01)

Study of neoadjuvant chemoradiotherapy with combined S-1 and low-dose cisplatin for patients with clinical stage II/III esophageal cancer
by: Kodai Takahashi, et al.
Published: (2018-03-01)

Effect of kanglaite injection and docetaxel in treating advanced stage esophageal cancer on tumor markers, angiogenesis and immune function in elderly patients
by: Yong-Gang Luo, et al.
Published: (2018-06-01)

Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis
by: Xinfang Yu, et al.
Published: (2017-06-01)

Preoperative chemoradiation in locally advanced rectal cancer: A comparison of bolus 5-fluorouracil/leucovorin and capecitabine
by: Adnan Yoney, et al.
Published: (2014-01-01)

Effect of paclitaxel + cisplatin chemotherapy before radical operation for esophageal cancer on the malignant degree of tumor
by: Wei Chen
Published: (2018-10-01)

RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes
by: Rui‐Jie Zeng, et al.
Published: (2019-09-01)